Sarah Ketterer’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sarah Ketterer's BMY Position: Q3 2026 in Review
Sarah Ketterer opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,673 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #111 among its holdings. This is a return to the name: Sarah Ketterer previously reported a position in BMY as recently as Q3 2024.
Sarah Ketterer first reported a position in BMY in Q2 2024 and has held it in 3 quarters since. The position peaked at $38.8M in Q3 2024. 2,566 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Sarah Ketterer held 3,673 shares of Bristol-Myers Squibb worth $229K as of Q3 2026.
- Bristol-Myers Squibb was a new Sarah Ketterer position in Q3 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Sarah Ketterer's portfolio in Q3 2026, its #111 holding.
- Sarah Ketterer first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 3 quarters since.
- Sarah Ketterer's Bristol-Myers Squibb position peaked at $38.8M in Q3 2024.
- 2,566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Causeway Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.